2026/02/13 IR Notice Regarding Revision of Consolidated Earnings Forecast for the Fiscal Year Ending March 31, 2026, and Revision of Year-end Dividend Forecast
2024/04/30 Product NOF CORPORATION and Phosphorex Collaborate to Supply Lipid Nanoparticle Formulations Using NOF’s Proprietary Ionizable Lipid, COATSOME® SS Series
2026/03/06 Exhibit NOF to Exhibit and Present at 5th Annual LNP Formulation & Process Development Summit